CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 122 filers reported holding CRINETICS PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $18 | -99.9% | 1,000 | 0.0% | 0.00% | – |
| Q3 2022 | $19,000 | -89.3% | 1,000 | -85.8% | 0.00% | -100.0% |
| Q4 2019 | $177,000 | +293.3% | 7,066 | +134.5% | 0.00% | +100.0% |
| Q3 2019 | $45,000 | -43.0% | 3,013 | -4.7% | 0.00% | 0.0% |
| Q2 2019 | $79,000 | +9.7% | 3,161 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $72,000 | -24.2% | 3,161 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $95,000 | +4.4% | 3,161 | 0.0% | 0.00% | +100.0% |
| Q3 2018 | $91,000 | – | 3,161 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 479,681 | $21,484,912 | 8.12% |
| New Leaf Venture Partners, L.L.C. | 141,000 | $6,315,390 | 7.68% |
| STEMPOINT CAPITAL LP | 551,095 | $24,683,545 | 7.25% |
| EcoR1 Capital, LLC | 4,155,375 | $186,119,246 | 5.69% |
| ACUTA CAPITAL PARTNERS, LLC | 135,141 | $6,052,965 | 5.10% |
| First Light Asset Management, LLC | 1,200,508 | $53,770,753 | 4.71% |
| Ikarian Capital, LLC | 588,818 | $26,373,158 | 4.59% |
| Paradigm Biocapital Advisors LP | 2,513,302 | $112,570,797 | 4.31% |
| MPM BioImpact LLC | 557,184 | $24,956,271 | 3.88% |
| Cormorant Asset Management, LP | 1,350,000 | $60,466,500 | 3.49% |